G2S2 Capital Inc. has acquired 147,000 common shares of Knight Therapeutics Inc., an Ontario-based specialty pharmaceutical company, through G2S2’s subsidiary Armco Alberta Inc., for $5.35 per share, in addition to the 12,118,600 common shares of Knight that G2S2 already owns before this transaction.

Through market transactions, private agreements, or other means, G2S2 may from time to time, contingent upon market and other factors, enhance or decrease its beneficial ownership, control, or direction over common shares of Knight.